Angela Thedinga
Director/Board Member at NKARTA, INC.
Net worth: - $ as of 2024-04-29
Profile
Angela M.
Thedinga is an Independent Director at Nkarta, Inc. She was previously the Chief Technology Officer at Adverum Biotechnologies, Inc. from 2020 to 2021 and the Chief of Staff & VP-Program Management at Novartis Gene Therapies, Inc. from 2018 to 2019.
Ms. Thedinga has a graduate degree from Massachusetts Institute of Technology, an undergraduate degree from the University of Wisconsin, a graduate degree from The University of North Carolina at Chapel Hill, and an MBA from MIT Sloan School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NKARTA, INC.
-.--% | 2024-04-14 | 0 ( -.--% ) | - $ | 2024-04-29 |
Angela Thedinga active positions
| Companies | Position | Start |
|---|---|---|
| NKARTA, INC. | Director/Board Member | 2022-03-27 |
Former positions of Angela Thedinga
| Companies | Position | End |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2021-09-30 |
| AVEXIS INC | Human Resources Officer | 2019-05-31 |
Training of Angela Thedinga
| Massachusetts Institute of Technology | Graduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
| The University of North Carolina at Chapel Hill | Graduate Degree |
| University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Angela Thedinga
